BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1373702)

  • 21. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The radical treatment of gastric carcinoma.
    Ranzato R; Fiamingo P; Veroux M; D'Amico DF
    Minerva Chir; 2004 Oct; 59(5):471-7. PubMed ID: 15494674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and prognosis of recurrent gastric cancer--is routine follow-up after gastrectomy worthwhile?
    Böhner H; Zimmer T; Hopfenmüller W; Berger G; Buhr HJ
    Hepatogastroenterology; 2000; 47(35):1489-94. PubMed ID: 11100384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric adenocarcinoma with distant metastasis: is gastrectomy necessary?
    Sarela AI; Yelluri S;
    Arch Surg; 2007 Feb; 142(2):143-9; discussion 149. PubMed ID: 17309965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reoperation for intraluminal rectal cancer recurrence.
    Rudmik LR; Buie WD; Heine JA
    Dis Colon Rectum; 2005 Sep; 48(9):1752-4. PubMed ID: 15991062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sacral recurrence of rectal carcinoma].
    Schumpelick V; Braun J
    Chirurg; 1995 Oct; 66(10):931-40. PubMed ID: 8529445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indications and results of palliative gastric resection in advanced gastric carcinoma].
    Dittmar Y; Voigt R; Heise M; Rabsch A; Jandt K; Settmacher U
    Zentralbl Chir; 2009 Feb; 134(1):77-82. PubMed ID: 19242887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Palliative treatment of adenocarcinoma of the cardia: is there a role for surgery?].
    Schmitt G; Sauvanet A; Berthoux L; Valverde A; Dugué L; Fékété F; Belghiti J
    Gastroenterol Clin Biol; 1998; 22(8-9):669-74. PubMed ID: 9823554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the postoperative course 113 patients with early gastric cancer.
    Yasuna O; Hayashi S
    Jpn J Clin Oncol; 1986 Dec; 16(4):325-34. PubMed ID: 3025477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of carcinoma of the gallbladder: a single-institution experience in 16 years.
    Chan SY; Poon RT; Lo CM; Ng KK; Fan ST
    J Surg Oncol; 2008 Feb; 97(2):156-64. PubMed ID: 18050290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment outcome of palliative (R1/R2) resection of stomach carcinoma].
    Piso P; Jähne J; Meyer HJ; Pichlmayer R
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():130-2. PubMed ID: 9101811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palliative surgical treatment of gastric carcinoma, duration of survival in 217 cases.
    Zwaveling A
    Arch Chir Neerl; 1976; 28(1):5-12. PubMed ID: 59578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors in resected stomach carcinoma].
    Oertli D; Herzog U; Tondelli P
    Schweiz Med Wochenschr; 1994 Jun; 124(22):945-52. PubMed ID: 7518097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
    Morris M; Alvarez RD; Kinney WK; Wilson TO
    Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of curative, distal resection of stomach neoplasms].
    Baumann C; Uhlschmid G; Hollinger A; Largiadèr F
    Helv Chir Acta; 1980 Dec; 47(5):555-50. PubMed ID: 6259089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.